Nix

Manufacturer
Insight Pharmaceuticals
Effective date
2009-06-10
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:22:32

Label at a glance#

ProductNix
Active ingredientPermethrin
Label structure10 sections

Dosage and administration

Inspect all household members should be checked by another person for lice and/or nits (eggs) use a magnifying glass in bright light to help you see the lice and nits (eggs) use a tool, such as a comb or two unsharpened pencils to lift and part the hair look for tiny nits near the scalp, beginning at the back of the neck and behind the ears small sections of hair (1-2 inches wide) should be examined at a time unli...

Storage and handling

read all the directions in the Consumer Information Insert and warnings before use. Keep the carton. It contains important information. store at 20° to 25°C (68° to 77°F)

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

Active ingredient
(in each fluid ounce)
  Purpose
Permethrin 280 mg (1%)...................Lice treatment

Use

INDICATIONS & USAGE SECTION

treats head lice

Warnings

WARNINGS SECTION

For external use only

OTC - DO NOT USE SECTION

Do not use

  • on children under 2 months of age
  • near the eyes
  • inside the nose, ear, mouth, or vagina
  • on lice in eyebrows or eyelashes. See your doctor.

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you are

  • allergic to ragweed. May cause breathing difficulty or an asthmatic episode.

OTC - WHEN USING SECTION

When using this product

  • keep eyes tightly closed and protect eyes with a washcloth or towel
  • if product gets into the eyes, immediately flush with large amounts of water
  • scalp itching or redness may occur

OTC - STOP USE SECTION

Stop use and see a doctor if

  • breathing difficulty occurs
  • eye irritation occurs
  • skin or scalp irritation continues or infection occurs

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Inspect

  • all household members should be checked by another person for lice and/or nits (eggs)
  • use a magnifying glass in bright light to help you see the lice and nits (eggs)
  • use a tool, such as a comb or two unsharpened pencils to lift and part the hair
  • look for tiny nits near the scalp, beginning at the back of the neck and behind the ears
  • small sections of hair (1-2 inches wide) should be examined at a time
  • unlike dandruff, nits stick to the hair. Dandruff should move when lightly touched.
  • if either lice or nits (eggs) are found, treat with Nix Creme Rinse

Treat

  • wash hair with a shampoo without conditioner. Do not use a shampoo that contains a conditioner or a conditioner alone since this may decrease the activity of Nix. Rinse with water.
  • towel dry hair so it is damp but not wet
  • shake the bottle of Nix well
  • completely saturate the hair and scalp with Nix. Begin to apply Nix behind the ears and at the back of the neck.
  • keep Nix out of the eyes. Protect the eyes with a washcloth or towel.
  • leave Nix on the hair for 10 minutes, but no longer
  • rinse with warm water
  • towel dry hair and comb out tangles
  • if live lice are seen seven days or more after the first treatment, a second treatment should be given

Remove Lice/Nits

  • remove nits by combing the hair with the special small tooth comb provided. Remaining nits may be removed by hand (using a throw-away glove), or cutting the nits out.
  • use the nit comb provided and make sure the hair remains slightly damp while removing nits
  • if the hair dries during combing, dampen it slightly with water
  • part the hair into 4 sections. Work on one section at a time. Longer hair may take more time (1-2 hours).
  • start at the top of the head on the section you have picked
  • with one hand, lift a 1-2 inch wide strand of hair. Get the teeth of the comb as close to the scalp as possible and comb with a firm, even motion away from the scalp to the end of the hair.
  • use clips to pin back each strand of hair after you have combed out the nits
  • clean the comb completely as you go. Wipe the nits from the comb with a tissue and throw away the tissue in a sealed plastic bag to prevent the lice from coming back.
  • after combing, recheck the entire head for nits and repeat combing if necessary
  • check the affected head daily to remove any nits that you might have missed

Other information

STORAGE AND HANDLING SECTION

  • read all the directions in the Consumer Information Insert and warnings before use. Keep the carton. It contains important information.
  • store at 20° to 25°C (68° to 77°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

balsam canada, cetyl alcohol, citric acid, FD&C yellow no. 6, fragrance, hydrolyzed animal protein, hydroxyethylcellulose, polyoxyethylene 10 cetyl ether, propylene glycol, stearalkonium chloride, water, isopropyl alcohol 5.6 g (20%), methylparaben 56 mg (0.2%), and propylparaben 22 mg (0.08%)

Questions or comments?

OTC - QUESTIONS SECTION

call 1-888-LICE LINE (1-888-542-3546), Monday to Friday, 9 AM - 5 PM EST

For a description of all of our products visit us at www.nixlice.com

PRINCIPAL DISPLAY PANEL - 2 FL OZ Bottle Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

The #1 Choice of Pharmacists

Nix®
Permethrin
LICE TREATMENT

Complete Lice
Treatment System

Single Application Kills Lice & Their Eggs
And Prevents Reinfestation For 14 days

This package contains
all of the following:

  • Nix Creme Rinse
    (Permethrin)
  • Metal Lice Comb with
    Detangling Feature
  • Disposable Application
    Gloves
  • Hair Salon Cape
  • 5' × 5' Drop Cloth

Contains Everything
Needed For An
Application

NET WT 2 FL OZ (59 ml)

PRINCIPAL DISPLAY PANEL - 2 FL OZ Bottle Carton
PRINCIPAL DISPLAY PANEL - 2 FL OZ Bottle Carton

NIX® Creme Rinse

SPL MEDGUIDE SECTION

INDICATIONS

NIX® Creme Rinse is indicated for the treatment of infestation with head lice and their nits (eggs). This unique creme rinse leaves the hair manageable and easy to comb.

WHAT ARE HEAD LICE?

Head lice are small insects that live and feed on the human scalp causing itching and irritation. They range in colour from beige to black. Lice lay eggs, called nits, on the hair shaft close to the scalp. The nits are tiny, oval shaped and shiny, and range in colour from creamy white to brown. Nits normally hatch in 7 to 10 days. The adult lice cannot survive away from the head for much more than 24 hours.

HOW DOES A LICE INFESTATION SPREAD?

Head lice spread easily, primarily by close head-to-head contact with persons who have lice and occasionally by sharing personal articles such as clothing, hats, combs, hair accessories, towels and bed linen.

WHAT TO DO IF YOU OR A MEMBER OF YOUR FAMILY HAS HEAD LICE

Head lice affect millions of people each year, especially school-aged children. They do not transmit or cause disease and are not a sign of poor personal hygiene. A head lice infestation can be effectively treated with a topical pediculicide and ovicide treatment (a treatment effective at destroying lice and their eggs) such as NIX Creme Rinse.

DIRECTIONS FOR USE OF NIX® CREME RINSE

  1. Wash the hair with conditioner-free shampoo. Do not use a conditioner. Rinse with water and towel dry thoroughly.
  2. Shake NIX bottle well. Apply a sufficient amount of NIX (1/2 to 1 bottle) to thoroughly saturate the hair and scalp, especially behind the ears and at the base of the neck.
  3. Leave NIX on the hair for 10 minutes.
  4. Rinse NIX off hair with water.
  5. Towel dry hair.
  6. Comb hair with regular comb to remove tangles.
  7. Remove nits: Part hair into sections; starting as close to the scalp as possible, remove the nits using the nit removal comb provided. Be sure to comb to the end of the hair shaft. The nit comb should be disinfected by soaking in hot water after each use. Inspect full head of hair thoroughly for any stray nits. The nit removal procedure should be repeated daily for the 7 days following treatment.

A single application is usually sufficient to eliminate a head lice infestation. The active ingredient in NIX persists on the hair for 10 days, even after subsequent washing with a conditioner-free shampoo. If you see live lice or nits after the first application, the residual effect should kill these. If you still see live lice or nits on the 7th day (or after) following the first application, NIX Creme Rinse should be applied a second time, as described above.

HOW TO HELP PREVENT REINFESTATION

Cleaning of personal articles is also an important part of head lice management and may help prevent reinfestation. Personal belongings including recently worn clothing, towels and bed linens should be machine washed in hot water and dried using the hot cycle of the dryer for at least 20 minutes. Personal articles of clothing or bedding that cannot be washed may be dry cleaned or sealed in a plastic bag for a period of two weeks. Combs and brushes should be disinfected by soaking in hot water (above 130°F/54°C) for 5 to 10 minutes.

Children should be advised not to use any borrowed combs or brushes, nor wear anyone else's clothes, especially hats.

Inspect all family members from time to time for any new lice infestation. If a new infestation is found treat with NIX Creme Rinse.

PRECAUTIONS

General: Head lice infestation is often accompanied by itching, redness, and swelling. Treatment with NIX may temporarily worsen these conditions. Do not use if allergic to any of its ingredients, synthetic pyrethroids or pyrethrin, or chrysanthemums. Discontinue use if reaction occurs.

Eye Irritation: NIX is not irritating to eyes; however, if it should get into them, rinse eyes immediately with water.

In Case of Swallowing: Consult your doctor or Poison Control Centre immediately.

Use in Pregnant or Nursing Women: There are no adequate or well-controlled studies in pregnant or nursing women. Consult a doctor before using this drug.

Use in Children: NIX is safe and effective in children two months of age and older. Safety and effectiveness in children less than two months of age have not been established. Consult your doctor.

Keep out of reach of children. To prevent accidental ingestion by children, the remaining contents of NIX should be discarded after use.

ADVERSE REACTIONS

In clinical studies, occasional itching has been known to occur. This is usually a consequence of head lice infestation itself, but may be temporarily worsened following treatment with NIX. Other reactions which are less frequent include: stinging/burning, tingling, numbness or discomfort, redness, and swelling or rash of the scalp. All these reactions are mild and temporary.

MEDICINAL INGREDIENT

Permethrin is the active ingredient in NIX Creme Rinse; it is present at a concentration of 1%.

NON-MEDICINAL INGREDIENTS (ALPHABETICALLY)

In addition, NIX Creme Rinse also contains the following non-active components: balsam Canada, cetyl alcohol, citric acid, FD&C Yellow No. 6, fragrance, hydrolyzed animal protein, hydroxyethylcellulose, isopropyl alcohol, parabens, polyoxyethylene cetyl ether, propylene glycol, stearalkonium chloride and water.

Comments or Questions ? 1-888-542-3546 or visit us at www.insightpharma.com
Distributed by: INSIGHT Pharmaceuticals Corp.
Langhorne, PA 19049-1749

66621A

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
763066Nix Cream Rinse 1 % Medicated ShampooPSN1
250387permethrin 1 % Medicated ShampooPSN1
763066permethrin 10 MG/ML Medicated Shampoo [Nix Cream Rinse]SBD1
250387permethrin 10 MG/ML Medicated ShampooSCD1
763066Nix Cream Rinse 1 % Medicated ShampooSY1
763066Nix Cream Rinse 10 MG/ML Medicated ShampooSY1
250387permethrin 1 % Medicated ShampooSY1
250387permethrin 1 % Topical LotionSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
PERMETHRIN Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
f33e3e13-1328-47a9-3012-134a14fcb6a1Product name220190703

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
63736-024-032019-10-21C16284748780-1956f9ecf-cd2c-621f-e053-dbdaa90a74adNix ® Lice Killing Creme Rinse

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63736-024-03Nix59 mL in 1 BOTTLESHAMPOO591
63736-024-03Nix1 in 1 CARTONSHAMPOO11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63736-024NIX (PERMETHRIN) SHAMPOO [INSIGHT PHARMACEUTICALS]1Legacy NDC, 2 package rows20090629_8bc95ef1-ea25-4ae7-a6e4-57e3e300a2c1.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
63736-024-03ML - Milliliter63736-024edae0d8b-ee49-4c7a-9d75-27b6627413e912017-10-13
63736-024-04ML - Milliliter63736-024dadced74-ab25-4fa4-af43-6eae607d479e12019-04-11

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
PermethrinACTIVE INGREDIENT509F88P9SZ1
PermethrinACTIVE MOIETY509F88P9SZ1
Cetyl alcoholINACTIVE INGREDIENT936JST6JCN1
citric acid monohydrateINACTIVE INGREDIENT2968PHW8QP1
FD&C yellow no. 6INACTIVE INGREDIENTH77VEI93A81
isopropyl alcoholINACTIVE INGREDIENTND2M4163021
methylparabenINACTIVE INGREDIENTA2I8C7HI9T1
propylene glycolINACTIVE INGREDIENT6DC9Q167V31
propylparabenINACTIVE INGREDIENTZ8IX2SC1OH1
stearalkonium chlorideINACTIVE INGREDIENT0OUO26BB881
waterINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
63736-02463736-024-03

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 7 · 380 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
citric acid monohydrateCITRIC ACID MONOHYDRATE2968PHW8QPINJECTION / EPIDURAL0.02 %w/vExact identifier — unii candidate
88 equally ranked IID candidates
FD&C yellow no. 6FD&C YELLOW NO. 6H77VEI93A8SYRUP / ORAL4 mg/5mlExact identifier — unii candidate
34 equally ranked IID candidates
propylparabenPROPYLPARABENZ8IX2SC1OHSOLUTION / NASAL140 mgExact identifier — unii candidate
68 equally ranked IID candidates
methylparabenMETHYLPARABENA2I8C7HI9TPOWDER, FOR SOLUTION / ORAL126 mgExact identifier — unii candidate
79 equally ranked IID candidates
methylparabenMETHYLPARABENA2I8C7HI9TINJECTION / INTRA-ARTICULAR0.24 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3SPRAY, METERED / NASAL240 mgExact identifier — unii candidate
81 equally ranked IID candidates
propylparabenPROPYLPARABENZ8IX2SC1OHINJECTION, SUSPENSION / SUBCUTANEOUS0.02 %w/vExact identifier — unii candidate
68 equally ranked IID candidates
methylparabenMETHYLPARABENA2I8C7HI9TINJECTION / INTRAVENOUS95 mgExact identifier — unii candidate
79 equally ranked IID candidates
citric acid monohydrateCITRIC ACID MONOHYDRATE2968PHW8QPINJECTION, POWDER, FOR SOLUTION / INTRAMUSCULARNAExact identifier — unii candidate
88 equally ranked IID candidates
propylparabenPROPYLPARABENZ8IX2SC1OHGEL / TOPICAL4 mgExact identifier — unii candidate
68 equally ranked IID candidates
methylparabenMETHYLPARABENA2I8C7HI9TDROPS / OPHTHALMIC0.01 %w/wExact identifier — unii candidate
79 equally ranked IID candidates
FD&C yellow no. 6FD&C YELLOW NO. 6H77VEI93A8TABLET, ORALLY DISINTEGRATING / ORAL12 mgExact identifier — unii candidate
34 equally ranked IID candidates
FD&C yellow no. 6FD&C YELLOW NO. 6H77VEI93A8CAPSULE, COATED PELLETS / ORALNAExact identifier — unii candidate
34 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3INJECTION / INTRAMUSCULAR7459 mgExact identifier — unii candidate
81 equally ranked IID candidates
citric acid monohydrateCITRIC ACID MONOHYDRATE2968PHW8QPSYSTEM / TOPICAL0.2 mgExact identifier — unii candidate
88 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3SPRAY / SUBLINGUAL36 mgExact identifier — unii candidate
81 equally ranked IID candidates
FD&C yellow no. 6FD&C YELLOW NO. 6H77VEI93A8POWDER / ORAL20 mgExact identifier — unii candidate
34 equally ranked IID candidates
stearalkonium chlorideSTEARALKONIUM CHLORIDE0OUO26BB88LOTION / TOPICAL3.15 %w/wExact identifier — unii candidate
citric acid monohydrateCITRIC ACID MONOHYDRATE2968PHW8QPINJECTION / INTRA-ARTICULARADJ PHExact identifier — unii candidate
88 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3INJECTION, SOLUTION / SUBCUTANEOUS1.4 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3CLOTH / TOPICAL0.03 mg/mgExact identifier — unii candidate
81 equally ranked IID candidates
FD&C yellow no. 6FD&C YELLOW NO. 6H77VEI93A8GEL / TOPICALNAExact identifier — unii candidate
34 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3SOLUTION/ DROPS / OPHTHALMIC0.75 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
citric acid monohydrateCITRIC ACID MONOHYDRATE2968PHW8QPSOLUTION / INTRAVENOUS10 mgExact identifier — unii candidate
88 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3TABLET, COATED / ORAL16 mgExact identifier — unii candidate
81 equally ranked IID candidates
methylparabenMETHYLPARABENA2I8C7HI9TSOLUTION / RESPIRATORY (INHALATION)0.03 %w/wExact identifier — unii candidate
79 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3SOLUTION, CONCENTRATE / ORAL2590 mgExact identifier — unii candidate
81 equally ranked IID candidates
propylparabenPROPYLPARABENZ8IX2SC1OHSPRAY / NASAL0.2 mgExact identifier — unii candidate
68 equally ranked IID candidates
Cetyl alcoholCETYL ALCOHOL936JST6JCNSUSPENSION / OPHTHALMIC0.5 %w/vExact identifier — unii candidate
20 equally ranked IID candidates
FD&C yellow no. 6FD&C YELLOW NO. 6H77VEI93A8SPONGE / TOPICAL0.01 %w/wExact identifier — unii candidate
34 equally ranked IID candidates
FD&C yellow no. 6FD&C YELLOW NO. 6H77VEI93A8SUSPENSION, EXTENDED RELEASE / ORAL0.12 mg/5mlExact identifier — unii candidate
34 equally ranked IID candidates
propylparabenPROPYLPARABENZ8IX2SC1OHDROPS / NASAL14 mgExact identifier — unii candidate
68 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3SUSPENSION/ DROPS / TOPICAL0.75 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
citric acid monohydrateCITRIC ACID MONOHYDRATE2968PHW8QPFILM / SUBLINGUAL10 mgExact identifier — unii candidate
88 equally ranked IID candidates
FD&C yellow no. 6FD&C YELLOW NO. 6H77VEI93A8TABLET, FILM COATED / ORAL1 mgExact identifier — unii candidate
34 equally ranked IID candidates
FD&C yellow no. 6FD&C YELLOW NO. 6H77VEI93A8LOTION / TOPICALNAExact identifier — unii candidate
34 equally ranked IID candidates
citric acid monohydrateCITRIC ACID MONOHYDRATE2968PHW8QPTABLET, EFFERVESCENT / ORAL460 mgExact identifier — unii candidate
88 equally ranked IID candidates
propylparabenPROPYLPARABENZ8IX2SC1OHELIXIR / ORAL200 mgExact identifier — unii candidate
68 equally ranked IID candidates
methylparabenMETHYLPARABENA2I8C7HI9TCREAM, AUGMENTED / TOPICAL2 mgExact identifier — unii candidate
79 equally ranked IID candidates
citric acid monohydrateCITRIC ACID MONOHYDRATE2968PHW8QPPOWDER / ORAL840 mgExact identifier — unii candidate
88 equally ranked IID candidates
citric acid monohydrateCITRIC ACID MONOHYDRATE2968PHW8QPINJECTION / PERIDURALNAExact identifier — unii candidate
88 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3FILM / BUCCAL1.48 mgExact identifier — unii candidate
81 equally ranked IID candidates
citric acid monohydrateCITRIC ACID MONOHYDRATE2968PHW8QPDROPS / ORALNAExact identifier — unii candidate
88 equally ranked IID candidates
propylparabenPROPYLPARABENZ8IX2SC1OHCREAM / TOPICAL6 mgExact identifier — unii candidate
68 equally ranked IID candidates
methylparabenMETHYLPARABENA2I8C7HI9TAEROSOL, FOAM / TOPICAL0.16 %w/wExact identifier — unii candidate
79 equally ranked IID candidates
propylparabenPROPYLPARABENZ8IX2SC1OHJELLY / TOPICAL180 mgExact identifier — unii candidate
68 equally ranked IID candidates
Cetyl alcoholCETYL ALCOHOL936JST6JCNAEROSOL / TOPICAL1.16 %w/wExact identifier — unii candidate
20 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3LOTION, AUGMENTED / TOPICAL2070 mgExact identifier — unii candidate
81 equally ranked IID candidates
Cetyl alcoholCETYL ALCOHOL936JST6JCNCAPSULE, DELAYED RELEASE / ORAL59 mgExact identifier — unii candidate
20 equally ranked IID candidates
propylparabenPROPYLPARABENZ8IX2SC1OHTABLET, EXTENDED RELEASE / ORAL0.12 mgExact identifier — unii candidate
68 equally ranked IID candidates
FD&C yellow no. 6FD&C YELLOW NO. 6H77VEI93A8POWDER, FOR SUSPENSION / ORAL6 mgExact identifier — unii candidate
34 equally ranked IID candidates
citric acid monohydrateCITRIC ACID MONOHYDRATE2968PHW8QPSOLUTION / AURICULAR (OTIC)0.2 %w/vExact identifier — unii candidate
88 equally ranked IID candidates
FD&C yellow no. 6FD&C YELLOW NO. 6H77VEI93A8CAPSULE, COATED / ORAL0.03 mgExact identifier — unii candidate
34 equally ranked IID candidates
methylparabenMETHYLPARABENA2I8C7HI9TSOLUTION / INTRAVENOUS0.13 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
FD&C yellow no. 6FD&C YELLOW NO. 6H77VEI93A8TABLET / ORAL60.02 mgExact identifier — unii candidate
34 equally ranked IID candidates
propylparabenPROPYLPARABENZ8IX2SC1OHSUSPENSION / SUBCUTANEOUS0.02 %w/vExact identifier — unii candidate
68 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3SOLUTION / INTRAVENOUS5 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
citric acid monohydrateCITRIC ACID MONOHYDRATE2968PHW8QPSOLUTION, CONCENTRATE / INTRAVENOUSNAExact identifier — unii candidate
88 equally ranked IID candidates
citric acid monohydrateCITRIC ACID MONOHYDRATE2968PHW8QPSOLUTION/ DROPS / TOPICAL0.01 %w/vExact identifier — unii candidate
88 equally ranked IID candidates
Cetyl alcoholCETYL ALCOHOL936JST6JCNEMULSION / TOPICALNAExact identifier — unii candidate
20 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N019918-001NIXPERMETHRIN1%LOTION / TOPICALRLD, RS1990-05-02

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-0284e616aacf4f…
2026-08-18 06:07:402026-07N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-02caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-02011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-0231067a03dcf5…
2025-08-23 18:47 UTC2025-08N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-026a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-02fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-02b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-0203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-022680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-025bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-02d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-02d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-0279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-02301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-021e350fbaab3a…
2024-05-31 18:47 UTC2024-05N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-028072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-025c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-025d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-024b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-0274a2ff9319b5…
2022-03-09 01:35 UTC2022-03N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-02bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-02782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-0287673890dc5c…
2021-03-12 10:30 UTC2021-03N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-025aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-028869cabd3fbd…
2020-11-12 02:37 UTC2020-11N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-02c0c555d07b60…
2019-12-14 00:12 UTC2019-12N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-023f01610625f2…
2019-09-15 20:21 UTC2019-09N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-02b00525d2431f…
2019-07-19 19:46 UTC2019-07N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-02ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-026a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-021c564ffb4f44…
2023-12-20 04:57 UTC2023-12N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-02ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-02a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-029b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-02a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-023f0d92c62455…
2023-05-13 08:27 UTC2023-05N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-02053a50430f4f…
2023-01-26 05:58 UTC2023-01N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-023bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-023a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N019918-001NIX1%LOTION / TOPICALRLD, RS1990-05-02f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
5d596cc9-d8d0-4cc4-9b9d-cd303330e9b58bc95ef1-ea25-4ae7-a6e4-57e3e300a2c12009-06-10WarningsExact identifier
spl id: 5d596cc9-d8d0-4cc4-9b9d-cd303330e9b5
spl set id: 8bc95ef1-ea25-4ae7-a6e4-57e3e300a2c1

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.